Formulation and Evaluation of floating tablets of Antiretroviral drug Lamivudine
Corresponding Author(s) : Balaji Maddiboyina
International Journal of Allied Medical Sciences and Clinical Research,
Vol. 9 No. 3 (2021): 2021 Volume - 9 Issue - 3
The purpose of this research was to prepare and evaluate floating drug delivery system of lamivudine. Floating tablets of lamivudine were developed to prolong gastric residence time and increase its bioavailability. Rapid gastrointestinal transit could result in incomplete drug release from the drug delivery system above the absorption zone leading to diminished efficacy of the administered dose. The tablets were prepared by direct compression technique, using polymers such as hydroxyl propyl methyl cellulose (HPMC K15M and HPMC K4M ), Ethyl cellulose combination and other standard excipients. Sodium bicarbonate was incorporated as a gas-generating agent. The effects of different concentrations of hydroxyl propyl methyl cellulose (HPMC K15M and HPMC K4M ) and EC on drug release profile and floating properties were investigated. Comparable release profiles between the commercial product and the designed system were obtained. The model fitting showed that the optimized formulation F5 formulations followed Korsmeyer and Peppas model, which had a higher value of correlation coefficient (r). While tablet hardness had little or no effect on the release kinetics and was found to be a determining factor with regards to the buoyancy of the tablets.
Download CitationEndnote/Zotero/Mendeley (RIS)
2. Garg R, Gupta GD. Progress in controlled gatroretentive delivery systems. Tropical J Pharm Res 2008;7(3):1055- 66.
3. Ashford M. The gastrointestinal physiology and drug absorption. In: Pharmaceutics the science of dosage form design. Aulton ME, editor. Pharmaceutics the science of dosage form design. 2nd ed. Edinburgh: Churchill living stone. 2004; 220.
4. Wilson KR, Waugh A. Anatomy and physiology in health and illness, 9th ed. London: Churchill Livingstone; 1996.
5. Wilson CG, Washington N. The stomach: its role in oral drug delivery. Physiological Pharmaceutical: Biological Barriers to Drug Absorption. Chichester, UK: Ellis Horwood;1989:47-70.
6. Wong DSL. Prolonged release active agent dosage form adapted for gastric retention. US Patent 2000; 15th Sept: 120-803.
7. Yuveraj Singh T, Naruk PS, Ojha GR. Development and evaluation of floating microspheres of Verpamil Hydrochloride. Braz J pharmasci 2007;43(4):529-34.
8. Gattani YS, Kawtikwar PS, Sakarka DM. Formulation & evaluation of gastro retentive multi-particulate drug delivery system of Aceclofenac. Int J ChemTech Res 2009;1(1):1-10.
9. Yeole PG, Khan S, Patel VF. Floating drug delivery systems: Need and development. Indian J pharmaSci 2005;67(3):265-72.
10. Timmermans J, Moes AJ. Floating dosages forms: A Review. Int J Pharm 1990;62:207-16.
11. Rosa M, Zia H, Rhodes T. Dosing and testing in-vitro of a bioadhesive and floating drug delivery system for oral application. Int J Pharm. 1994;105:65–70.
12. Fursule RA, Patra CN, patil GB, Kosalge SB, patil PO, Deshmukh PK. Study of multiparticulate floating drug delivery system prepared by emulsion gelation technique. Int J Chem Tech Res 2009;1(2):162-7.
13. Kumaresh SS, Tejraj MA, Sunil AA, Nadagouda NM, Padmakar VK. Effect of coexcipient on drug release and floating property of Nifedipine hollow microspheres: a novel gastro retentive drug delivery system. J ApplPolymSci 2006;100:486-94.